Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Efficacy and safety of JAK3 inhibitors in allergic asthma validated using WHI-P97

Jan. 9, 2001

Antiinflammatory compounds from Bayer act as PDE4 inhibitors

Jan. 8, 2001

Antiinflammatory and antiemetic effects of YM-976 evaluated in animal studies

Jan. 8, 2001

Use of (S)-oxybutynin for asthma claimed by Sepracor in recent patent

Jan. 4, 2001

Anticholinergic bronchodilator proves safe and effective as COPD maintenance therapy

Jan. 4, 2001

Novel antiinflammatory agents described by Bayer group

Jan. 2, 2001

Aventis team describes preparation and use of new cell adhesion, migration inhibitors

Jan. 2, 2001

PDE4 inhibitors from Merck Frosst

Dec. 29, 2000

Mitsubishi Chemical reveals unique compound with potential for treatment of inflammatory disorders

Dec. 29, 2000

Glaxo Wellcome receives E.U. approval for Seretide MDI for the treatment of asthma

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...